Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.8316
+0.0026 (0.31%)
At close: Sep 28, 2026, 4:00 PM EDT
0.8700
+0.0384 (4.62%)
After-hours: Sep 28, 2026, 7:59 PM EDT
Tempest Therapeutics Employees
Tempest Therapeutics had 4 employees as of June 30, 2026. The number of employees decreased by 17 or -80.95% compared to the same quarter last year.
Employees
4
Change
-17
Growth
-80.95%
Revenue / Employee
n/a
Profits / Employee
-$10,118,000
Market Cap
13.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 4 | -17 | -80.95% |
| Mar 31, 2026 | 5 | -19 | -79.17% |
| Dec 31, 2025 | 4 | -20 | -83.33% |
| Sep 30, 2025 | 5 | -19 | -79.17% |
| Jun 30, 2025 | 21 | - | - |
| Dec 31, 2024 | 24 | 7 | 41.18% |
| Dec 31, 2023 | 17 | -2 | -10.53% |
| Dec 31, 2022 | 19 | 2 | 11.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 113 |
| Vistagen Therapeutics | 41 |
| Passage Bio | 24 |
| Lisata Therapeutics | 21 |
| IN8bio | 18 |
| Lantern Pharma | 16 |
| AEON Biopharma | 8 |
| Intensity Therapeutics | 7 |
TPST News
- 3 days ago - Tempest Therapeutics files to sell 9.53M shares of common stock for holders - TheFly
- 3 days ago - Tempest Therapeutics Registration statement: Registration filing - Filings
- 4 days ago - Tempest Therapeutics price target lowered to $7 from $11 at H.C. Wainwright - TheFly
- 5 days ago - Tempest Therapeutics appoints Freda-Smith to board of directors - TheFly
- 5 days ago - Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors - GlobeNewsWire
- 12 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 13 days ago - Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform - GlobeNewsWire
- 13 days ago - Tempest Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts